Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mast Cells in the Tumor Microenvironment
Angélica Aponte-López, Samira Muñoz-Cruz
Advances in experimental medicine and biology (2020), pp. 159-173
Closed Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 142
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 78
Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications
Jian-Wen Fang, Yue Lu, Jingyan Zheng, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 9
Open Access | Times Cited: 73
Pericytes in the tumor microenvironment
Zhongyi Jiang, Jing Zhou, Luohong Li, et al.
Cancer Letters (2023) Vol. 556, pp. 216074-216074
Open Access | Times Cited: 68
Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics
Tosin Akinsipe, Rania Mohamedelhassan, Ayuba Akinpelu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment
Yu-Heng Zhu, Jia-Hao Zheng, Qin-Yuan Jia, et al.
Cellular Oncology (2022) Vol. 46, Iss. 1, pp. 17-48
Closed Access | Times Cited: 57
Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma
Jiayang Cai, Yuanyuan Hu, Zhang Ye, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Mast Cell–Tumor Interactions: Molecular Mechanisms of Recruitment, Intratumoral Communication and Potential Therapeutic Targets for Tumor Growth
Deisy Segura-Villalobos, Itzel G. Ramírez-Moreno, Magnolia Martínez-Aguilar, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 349-349
Open Access | Times Cited: 44
Remodeling tumor microenvironment with natural products to overcome drug resistance
Wanlu Zhang, Shubo Li, Chunting Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation
Lizhuang Shu, Xingyong Li, Zengli Liu, et al.
Hepatology (2023) Vol. 79, Iss. 2, pp. 307-322
Closed Access | Times Cited: 32
Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
Ying Li, Shuai Xiang, Wenjun Pan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 31
Mast cells in colorectal cancer tumour progression, angiogenesis, and lymphangiogenesis
Xiaoxin Liu, Xinyu Li, Haotian Wei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 30
Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment
Dan Wang, Yingying Han, Lushan Peng, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 7, pp. 2198-2219
Open Access | Times Cited: 23
Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment
Anda Shi, Zengli Liu, Zhongqi Fan, et al.
Gut (2024) Vol. 73, Iss. 8, pp. 1350-1363
Closed Access | Times Cited: 9
A review of natural products targeting tumor immune microenvironments for the treatment of lung cancer
Pengyu Yao, Liang Su, Zhenying Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Mast Cells at the Crossroads of Hypersensitivity Reactions and Neurogenic Inflammation
Ernesto Aitella, Ciro Romano, Lia Ginaldi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 927-927
Open Access | Times Cited: 1
Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer
Yuanyuan Zhang, Hongyan Chen, Hongnan Mo, et al.
Cancer Cell (2025)
Open Access | Times Cited: 1
GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma
Yanying Li, Jingliang Wu, Lu Qiao, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 2559-2575
Open Access | Times Cited: 30
Vital roles of m5C RNA modification in cancer and immune cell biology
Xinyu Gu, Xiao Ma, Chao Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma
Minglei Zhao, Hui Huang, Feng He, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
BAG6 restricts pancreatic cancer progression by suppressing the release of IL33-presenting extracellular vesicles and the activation of mast cells
Bilal Alashkar Alhamwe, Viviane Ponath, Fahd Alhamdan, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 8, pp. 918-931
Open Access | Times Cited: 7
A review concerning the breast cancer-related tumour microenvironment
Oscar Hernán Rodríguez-Bejarano, Carlos Parra-López, Manuel A. Patarroyo
Critical Reviews in Oncology/Hematology (2024) Vol. 199, pp. 104389-104389
Open Access | Times Cited: 6
Beyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression
Hussein Sabit, Borros Arneth, Shaimaa Abdel-Ghany, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1666-1666
Open Access | Times Cited: 6
Mast cell marker gene signature in head and neck squamous cell carcinoma
Zhimou Cai, Bingjie Tang, Lin Chen, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 25
PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy
Jun Li, Gang Peng, Kuikui Zhu, et al.
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 3, pp. 633-645
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top